Abstract:Exercise offers short-term and long-term health benefits, including an increased metabolic rate and energy expenditure in myocardium. The newly-discovered exercise-induced myokine, irisin, stimulates conversion of white into brown adipocytes as well as increased mitochondrial biogenesis and energy expenditure. Remarkably, irisin is highly expressed in myocardium, but its physiological effects in the heart are unknown. The objective of this work is to investigate irisin's potential multifaceted effects on cardiomyoblasts and myocardium. For this purpose, H9C2 cells were treated with recombinant irisin produced in yeast cells (r-irisin) and in HEK293 cells (hr-irisin) for examining its effects on cell proliferation by MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay and on gene transcription profiles by qRT-PCR. R-irisin and hr-irisin both inhibited cell proliferation and activated genes related to cardiomyocyte metabolic function and differentiation, including myocardin, follistatin, smooth muscle actin, and nuclear respiratory factor-1. Signal transduction pathways affected by r-irisin in H9C2 cells and C57BL/6 mice were examined by detecting phosphorylation of PI3K-AKT, p38, ERK or STAT3. We also measured intracellular Ca2+ signaling and mitochondrial thermogenesis and energy expenditure in r-irisin-treated H9C2 cells. The results showed that r-irisin, in a certain concentration rage, could activate PI3K-AKT and intracellular Ca2+ signaling and increase cellular oxygen consumption in H9C2 cells. Our study also suggests the existence of irisin-specific receptor on the membrane of H9C2 cells. In conclusion, irisin in a certain concentration rage increased myocardial cell metabolism, inhibited cell proliferation and promoted cell differentiation. These effects might be mediated through PI3K-AKT and Ca2+ signaling, which are known to activate expression of exercise-related genes such as follistatin and myocardin. This work supports the value of exercise, which promotes irisin release.

Irisin: a New Molecular Marker and Target in Metabolic Disorder

Irisin: a new molecular marker and target in metabolic disorder

Irisin Reverses Insulin Resistance in C2C12 Cells Via the P38-Mapk-pgc-1α Pathway.

Irisin, an Exercise‐induced Myokine As a Metabolic Regulator: an Updated Narrative Review

Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions

The Effect Of Irisin As A Metabolic Regulator And Its Therapeutic Potential For Obesity

Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process

Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome

Irisin in atherosclerosis

The Novel Myokine——Irisin

New insights into the roles of Irisin in diabetic cardiomyopathy and vascular diseases

Potential role of irisin in lung diseases and advances in research

Irisin, Energy Homeostasis and Male Reproduction

Irisin Controls Growth, Intracellular Ca2+ Signals, and Mitochondrial Thermogenesis in Cardiomyoblasts

Irisin and Energy Metabolism and the Role of Irisin on Metabolic Syndrome

Irisin: Linking Metabolism with Heart Failure.

The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease

Irisin Protects Musculoskeletal Homeostasis via a Mitochondrial Quality Control Mechanism

Myokines: Metabolic Regulation in Obesity and Type 2 Diabetes

The Role of the Myokine Irisin in the Protection and Carcinogenesis of the Gastrointestinal Tract

Potential role of irisin in digestive system diseases